BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 10920948)

  • 1. [Recurrent urothelial cancer after resection of ureteral carcinoma].
    Kong C; Ci J; Liu T
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining hand assisted laparoscopic nephroureterectomy with cystoscopic circumferential excision of the distal ureter without primary closure of the bladder cuff--is it safe?
    Kurzer E; Leveillee RJ; Bird VG
    J Urol; 2006 Jan; 175(1):63-7; discussion 67-8. PubMed ID: 16406870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate followup of hand assisted laparoscopic nephroureterectomy for urothelial carcinoma: factors associated with outcomes.
    Wolf JS; Dash A; Hollenbeck BK; Johnston WK; Madii R; Montgomery JS
    J Urol; 2005 Apr; 173(4):1102-7. PubMed ID: 15758710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urethral recurrence after cysto-prostatectomy for bladder tumor].
    Robert M; Burgel JS; Serre I; Guiter J; Grasset D
    Prog Urol; 1996; 6(4):558-63. PubMed ID: 8924933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.
    Toll AD; Epstein JI
    Am J Surg Pathol; 2012 Jul; 36(7):1081-6. PubMed ID: 22510761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urothelial cancer of the upper urinary tract].
    Jurincic-Winkler C; Horlbeck R; Gasser A; Glenewinkel J; Klippel KF
    Urologe A; 1993 Jul; 32(4):295-9. PubMed ID: 8372411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ureter cancer of complete double renal pelvis and ureter: a case report].
    Takagi S; Gohji K; Iwamoto Y; Masuda H; Segawa N; Kiura H; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 2002 Dec; 48(12):761-4. PubMed ID: 12613013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised?
    Giannarini G; Schumacher MC; Thalmann GN; Bitton A; Fleischmann A; Studer UE
    BJU Int; 2007 Aug; 100(2):264-8. PubMed ID: 17532855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical study of renal pelvic and ureteral cancer associated with bladder cancer].
    Sakaue K; Kakimoto K; Oda M; Kajikawa J; Koide T; Kobayashi Y
    Hinyokika Kiyo; 1996 Feb; 42(2):91-4. PubMed ID: 8712094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers.
    Nakanishi J; Wada Y; Matsumoto K; Azuma M; Kikuchi K; Ueda S
    Cancer Immunol Immunother; 2007 Aug; 56(8):1173-82. PubMed ID: 17186290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.